Drugs / ZX-7101A
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 17 trials | ||||||
| Phase 1 | NCT06841926 | Feb → Apr 2025 | viral respiratory tract infection | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT06057103 | Aug → Dec 2023 | — | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT05955027 | Jul → Aug 2023 | influenza | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT05949385 | Jul → Sep 2023 | — | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT05711797 | Apr 2023 → Feb 2024 | influenza | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT05720091 | Feb → Mar 2023 | influenza | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT05217732 | Dec 2021 → Aug 2022 | — | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05702489 | Jul 2022 → May 2023 | influenza | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT07095257 | Oct 2025 → Jan 2026 | viral respiratory tract infection | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT06669351 | Oct 2024 → Jul 2025 | viral respiratory tract infection | Nanjing Zenshine Pharmaceuticals | Terminated | No outcome recorded |
| Phase 3 | NCT06099873 | Nov 2023 → Feb 2025 | viral respiratory tract infection | Nanjing Zenshine Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZX-7101A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06099873 ↗ |
| Route | Oral | “Administered as a selected, single oral dose of ZX-7101A in fasting state and non-fasting (with food) state.” NCT05217732 ↗ |